4//SEC Filing
Temsamani Karim Saad 4
Accession 0001666071-23-000152
CIK 0001666071other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 7:53 PM ET
Size
9.2 KB
Accession
0001666071-23-000152
Insider Transaction Report
Form 4
Cardlytics, Inc.CDLX
Temsamani Karim Saad
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2023-12-05$8.21/sh−40,413$331,791→ 258,858 total - Exercise/Conversion
Restricted Stock Unit
2023-12-01−84,079→ 924,867 total→ Common Stock (84,079 underlying) - Exercise/Conversion
Common Stock
2023-12-01+84,079→ 299,271 total
Footnotes (5)
- [F1]Represents the underlying vested shares of common stock of the Issuer.
- [F2]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on December 1, 2023.
- [F3]The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
- [F5]25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.
Documents
Issuer
Cardlytics, Inc.
CIK 0001666071
Entity typeother
Related Parties
1- filerCIK 0001944491
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 7:53 PM ET
- Size
- 9.2 KB